Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA SUN PHARMA CIPLA/
SUN PHARMA
 
P/E (TTM) x 31.1 41.7 74.5% View Chart
P/BV x 5.0 6.7 74.4% View Chart
Dividend Yield % 0.6 0.7 80.2%  

Financials

 CIPLA   SUN PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-23
SUN PHARMA
Mar-23
CIPLA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1851,072 110.6%   
Low Rs852790 107.9%   
Sales per share (Unadj.) Rs281.9182.9 154.1%  
Earnings per share (Unadj.) Rs35.135.7 98.5%  
Cash flow per share (Unadj.) Rs49.746.2 107.4%  
Dividends per share (Unadj.) Rs8.5011.50 73.9%  
Avg Dividend yield %0.81.2 67.5%  
Book value per share (Unadj.) Rs289.2233.4 123.9%  
Shares outstanding (eoy) m807.152,399.34 33.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.65.1 71.0%   
Avg P/E ratio x29.026.1 111.1%  
P/CF ratio (eoy) x20.520.1 101.9%  
Price / Book Value ratio x3.54.0 88.3%  
Dividend payout %24.232.2 75.1%   
Avg Mkt Cap Rs m822,1642,233,361 36.8%   
No. of employees `000NANA-   
Total wages/salary Rs m38,30182,960 46.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,531438,857 51.8%  
Other income Rs m5,1218,199 62.5%   
Total revenues Rs m232,653447,055 52.0%   
Gross profit Rs m48,079112,900 42.6%  
Depreciation Rs m11,72125,294 46.3%   
Interest Rs m1,0951,720 63.7%   
Profit before tax Rs m40,38494,084 42.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,0298,476 141.9%   
Profit after tax Rs m28,35585,608 33.1%  
Gross profit margin %21.125.7 82.1%  
Effective tax rate %29.89.0 330.6%   
Net profit margin %12.519.5 63.9%  
BALANCE SHEET DATA
Current assets Rs m168,051398,619 42.2%   
Current liabilities Rs m50,333199,064 25.3%   
Net working cap to sales %51.745.5 113.8%  
Current ratio x3.32.0 166.7%  
Inventory Days Days73147 49.8%  
Debtors Days Days795 6.8%  
Net fixed assets Rs m117,318376,960 31.1%   
Share capital Rs m1,6142,399 67.3%   
"Free" reserves Rs m231,845557,555 41.6%   
Net worth Rs m233,460559,954 41.7%   
Long term debt Rs m00-   
Total assets Rs m290,067775,794 37.4%  
Interest coverage x37.955.7 68.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 138.7%   
Return on assets %10.211.3 90.2%  
Return on equity %12.115.3 79.4%  
Return on capital %17.817.1 103.8%  
Exports to sales %22.60-   
Imports to sales %8.90-   
Exports (fob) Rs m51,516NA-   
Imports (cif) Rs m20,202NA-   
Fx inflow Rs m64,282154,053 41.7%   
Fx outflow Rs m20,20271,511 28.2%   
Net fx Rs m44,08082,541 53.4%   
CASH FLOW
From Operations Rs m32,37749,593 65.3%  
From Investments Rs m-23,885-79,437 30.1%  
From Financial Activity Rs m-9,58323,761 -40.3%  
Net Cashflow Rs m-9681,155 -83.8%  

Share Holding

Indian Promoters % 13.4 54.5 24.7%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 36.6 136.6%  
FIIs % 25.7 17.1 150.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 45.5 146.2%  
Shareholders   425,731 612,626 69.5%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Cipla vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Sun Pharma Share Price Performance

Period Cipla Sun Pharma S&P BSE HEALTHCARE
1-Day -3.13% -0.48% -1.13%
1-Month -2.01% 2.22% -5.18%
1-Year 66.14% 62.69% 57.21%
3-Year CAGR 23.74% 39.30% 18.08%
5-Year CAGR 22.01% 27.22% 18.84%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of Cipla, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.